Profound Medical annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
Profound Medical Stock-Based Compensation Growth & History (PROF)
Profound Medical's stock-based compensation was $5.5M for fiscal 2025.
View full Profound Medical company overviewProfound Medical annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.5M | $2.9M | +112.71% |
| 2024 | 2024-12-31 | $2.6M | −$836,000 | −24.47% |
| 2023 | 2023-12-31 | $3.4M | −$821,000 | −19.37% |
| 2022 | 2022-12-31 | $4.2M | −$3.0M | −41.18% |
| 2021 | 2021-12-31 | $7.2M | $4.2M | +138.73% |
| 2020 | 2020-12-31 | $3.0M | $1.8M | +138.39% |
| 2019 | 2019-12-31 | $1.3M | — | — |
Profound Medical quarterly stock-based compensation
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $874,000 | −$577,000 | −39.77% |
| Q1 2026 | 2026-03-31 | $1.0M | $59,000 | +5.97% |
| Q4 2025 | 2025-12-31 | $1.4M | $939,000 | +212.44% |
| Q3 2025 | 2025-09-30 | $1.7M | $1.1M | +176.32% |
| Q2 2025 | 2025-06-30 | $1.5M | $683,000 | +88.93% |
| Q1 2025 | 2025-03-31 | $989,000 | $222,000 | +28.94% |
| Q4 2024 | 2024-12-31 | $442,000 | — | — |
| Q3 2024 | 2024-09-30 | $604,000 | — | — |
| Q2 2024 | 2024-06-30 | $768,000 | — | — |
| Q1 2024 | 2024-03-31 | $767,000 | — | — |
Profound Medical stock-based compensation trends
Over the last five fiscal years, Profound Medical's stock-based compensation increased from $3.0M to $5.5M, a change of $2.5M. The latest reported quarter, Q2 2026, shows $874,000.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Profound Medical source filings ↗